A retropharyngeal abscess is a serious infection, usually starts in the lymph nodes, characterised by collection of pus at the back of the throat. Retropharyngeal abscess typically occurs in children under the age of eight, sometimes it can also affect adults. The symptoms of retropharyngeal abscess include difficulty or noisy breathing, difficulty and pain while swallowing, drooling, severe cough, severe throat pain, neck stiffness or swelling, muscle spasms in the neck among others. Retropharyngeal abscess is generally preceded by upper respiratory infections mostly a middle ear or sinus infection._x000D_
A significant market share of the global retropharyngeal abscess market is held by the Americas, owing to high expenditure on the health care especially in major countries of the region like the U.S. and Canada. Additionally, the number of cardiac procedures in the U.S and Canada is increasing due to greater healthcare penetration, which drives the retropharyngeal abscess market. The high concentration of the major hospitals in the developed countries of this region coupled with good reimbursement rates is adding fuel to the market growth. Moreover, the large share of infective procedures treatment in the returns of hospitals favors the market. The large number of pharmaceutical companies in the U.S. is also a cause for the faster development of retropharyngeal abscess market in the US. The development of broad spectrum antibiotics in developed regions such as the U.S. and Europe is a strong driver of the market._x000D_
Market Analysis and Insights: Global Retropharyngeal Abscess Market_x000D_
The global Retropharyngeal Abscess market size is projected to reach US$ 4602 million by 2026, from US$ 4478.4 million in 2020, at a CAGR of 2.6%% during 2021-2026._x000D_
_x000D_
Global Retropharyngeal Abscess Scope and Market Size_x000D_
Retropharyngeal Abscess market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Retropharyngeal Abscess market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026._x000D_
The following players are covered in this report:_x000D_
Merck KGaA_x000D_
Johnson & Johnson_x000D_
AstraZeneca plc._x000D_
Sanofi S.A._x000D_
Pfizer_x000D_
Mylan N.V._x000D_
Novartis AG_x000D_
Teva pharmaceutical company_x000D_
GlaxoSmithKline plc._x000D_
Retropharyngeal Abscess Breakdown Data by Type_x000D_
Antibiotics_x000D_
Pain Killers_x000D_
Surgical Drainage_x000D_
Others_x000D_
Retropharyngeal Abscess Breakdown Data by Application_x000D_
Hospitals and Clinics_x000D_
Research and Academics_x000D_
Others
A significant market share of the global retropharyngeal abscess market is held by the Americas, owing to high expenditure on the health care especially in major countries of the region like the U.S. and Canada. Additionally, the number of cardiac procedures in the U.S and Canada is increasing due to greater healthcare penetration, which drives the retropharyngeal abscess market. The high concentration of the major hospitals in the developed countries of this region coupled with good reimbursement rates is adding fuel to the market growth. Moreover, the large share of infective procedures treatment in the returns of hospitals favors the market. The large number of pharmaceutical companies in the U.S. is also a cause for the faster development of retropharyngeal abscess market in the US. The development of broad spectrum antibiotics in developed regions such as the U.S. and Europe is a strong driver of the market._x000D_
Market Analysis and Insights: Global Retropharyngeal Abscess Market_x000D_
The global Retropharyngeal Abscess market size is projected to reach US$ 4602 million by 2026, from US$ 4478.4 million in 2020, at a CAGR of 2.6%% during 2021-2026._x000D_
_x000D_
Global Retropharyngeal Abscess Scope and Market Size_x000D_
Retropharyngeal Abscess market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Retropharyngeal Abscess market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026._x000D_
The following players are covered in this report:_x000D_
Merck KGaA_x000D_
Johnson & Johnson_x000D_
AstraZeneca plc._x000D_
Sanofi S.A._x000D_
Pfizer_x000D_
Mylan N.V._x000D_
Novartis AG_x000D_
Teva pharmaceutical company_x000D_
GlaxoSmithKline plc._x000D_
Retropharyngeal Abscess Breakdown Data by Type_x000D_
Antibiotics_x000D_
Pain Killers_x000D_
Surgical Drainage_x000D_
Others_x000D_
Retropharyngeal Abscess Breakdown Data by Application_x000D_
Hospitals and Clinics_x000D_
Research and Academics_x000D_
Others
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Retropharyngeal Abscess Revenue
1.4 Market by Type
1.4.1 Global Retropharyngeal Abscess Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Antibiotics
1.4.3 Pain Killers
1.4.4 Surgical Drainage
1.4.5 Others
1.5 Market by Application
1.5.1 Global Retropharyngeal Abscess Market Share by Application: 2020 VS 2026
1.5.2 Hospitals and Clinics
1.5.3 Research and Academics
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Retropharyngeal Abscess Market Perspective (2015-2026)
2.2 Global Retropharyngeal Abscess Growth Trends by Regions
2.2.1 Retropharyngeal Abscess Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Retropharyngeal Abscess Historic Market Share by Regions (2015-2020)
2.2.3 Retropharyngeal Abscess Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Retropharyngeal Abscess Market Growth Strategy
2.3.6 Primary Interviews with Key Retropharyngeal Abscess Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Retropharyngeal Abscess Players by Market Size
3.1.1 Global Top Retropharyngeal Abscess Players by Revenue (2015-2020)
3.1.2 Global Retropharyngeal Abscess Revenue Market Share by Players (2015-2020)
3.1.3 Global Retropharyngeal Abscess Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Retropharyngeal Abscess Market Concentration Ratio
3.2.1 Global Retropharyngeal Abscess Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Retropharyngeal Abscess Revenue in 2019
3.3 Retropharyngeal Abscess Key Players Head office and Area Served
3.4 Key Players Retropharyngeal Abscess Product Solution and Service
3.5 Date of Enter into Retropharyngeal Abscess Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Retropharyngeal Abscess Historic Market Size by Type (2015-2020)
4.2 Global Retropharyngeal Abscess Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Retropharyngeal Abscess Market Size by Application (2015-2020)
5.2 Global Retropharyngeal Abscess Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Retropharyngeal Abscess Market Size (2015-2020)
6.2 Retropharyngeal Abscess Key Players in North America (2019-2020)
6.3 North America Retropharyngeal Abscess Market Size by Type (2015-2020)
6.4 North America Retropharyngeal Abscess Market Size by Application (2015-2020)
7 Europe
7.1 Europe Retropharyngeal Abscess Market Size (2015-2020)
7.2 Retropharyngeal Abscess Key Players in Europe (2019-2020)
7.3 Europe Retropharyngeal Abscess Market Size by Type (2015-2020)
7.4 Europe Retropharyngeal Abscess Market Size by Application (2015-2020)
8 China
8.1 China Retropharyngeal Abscess Market Size (2015-2020)
8.2 Retropharyngeal Abscess Key Players in China (2019-2020)
8.3 China Retropharyngeal Abscess Market Size by Type (2015-2020)
8.4 China Retropharyngeal Abscess Market Size by Application (2015-2020)
9 Japan
9.1 Japan Retropharyngeal Abscess Market Size (2015-2020)
9.2 Retropharyngeal Abscess Key Players in Japan (2019-2020)
9.3 Japan Retropharyngeal Abscess Market Size by Type (2015-2020)
9.4 Japan Retropharyngeal Abscess Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Retropharyngeal Abscess Market Size (2015-2020)
10.2 Retropharyngeal Abscess Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Retropharyngeal Abscess Market Size by Type (2015-2020)
10.4 Southeast Asia Retropharyngeal Abscess Market Size by Application (2015-2020)
11 India
11.1 India Retropharyngeal Abscess Market Size (2015-2020)
11.2 Retropharyngeal Abscess Key Players in India (2019-2020)
11.3 India Retropharyngeal Abscess Market Size by Type (2015-2020)
11.4 India Retropharyngeal Abscess Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Retropharyngeal Abscess Market Size (2015-2020)
12.2 Retropharyngeal Abscess Key Players in Central & South America (2019-2020)
12.3 Central & South America Retropharyngeal Abscess Market Size by Type (2015-2020)
12.4 Central & South America Retropharyngeal Abscess Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Merck KGaA
13.1.1 Merck KGaA Company Details
13.1.2 Merck KGaA Business Overview
13.1.3 Merck KGaA Retropharyngeal Abscess Introduction
13.1.4 Merck KGaA Revenue in Retropharyngeal Abscess Business (2015-2020))
13.1.5 Merck KGaA Recent Development
13.2 Johnson & Johnson
13.2.1 Johnson & Johnson Company Details
13.2.2 Johnson & Johnson Business Overview
13.2.3 Johnson & Johnson Retropharyngeal Abscess Introduction
13.2.4 Johnson & Johnson Revenue in Retropharyngeal Abscess Business (2015-2020)
13.2.5 Johnson & Johnson Recent Development
13.3 AstraZeneca plc.
13.3.1 AstraZeneca plc. Company Details
13.3.2 AstraZeneca plc. Business Overview
13.3.3 AstraZeneca plc. Retropharyngeal Abscess Introduction
13.3.4 AstraZeneca plc. Revenue in Retropharyngeal Abscess Business (2015-2020)
13.3.5 AstraZeneca plc. Recent Development
13.4 Sanofi S.A.
13.4.1 Sanofi S.A. Company Details
13.4.2 Sanofi S.A. Business Overview
13.4.3 Sanofi S.A. Retropharyngeal Abscess Introduction
13.4.4 Sanofi S.A. Revenue in Retropharyngeal Abscess Business (2015-2020)
13.4.5 Sanofi S.A. Recent Development
13.5 Pfizer
13.5.1 Pfizer Company Details
13.5.2 Pfizer Business Overview
13.5.3 Pfizer Retropharyngeal Abscess Introduction
13.5.4 Pfizer Revenue in Retropharyngeal Abscess Business (2015-2020)
13.5.5 Pfizer Recent Development
13.6 Mylan N.V.
13.6.1 Mylan N.V. Company Details
13.6.2 Mylan N.V. Business Overview
13.6.3 Mylan N.V. Retropharyngeal Abscess Introduction
13.6.4 Mylan N.V. Revenue in Retropharyngeal Abscess Business (2015-2020)
13.6.5 Mylan N.V. Recent Development
13.7 Novartis AG
13.7.1 Novartis AG Company Details
13.7.2 Novartis AG Business Overview
13.7.3 Novartis AG Retropharyngeal Abscess Introduction
13.7.4 Novartis AG Revenue in Retropharyngeal Abscess Business (2015-2020)
13.7.5 Novartis AG Recent Development
13.8 Teva pharmaceutical company
13.8.1 Teva pharmaceutical company Company Details
13.8.2 Teva pharmaceutical company Business Overview
13.8.3 Teva pharmaceutical company Retropharyngeal Abscess Introduction
13.8.4 Teva pharmaceutical company Revenue in Retropharyngeal Abscess Business (2015-2020)
13.8.5 Teva pharmaceutical company Recent Development
13.9 GlaxoSmithKline plc.
13.9.1 GlaxoSmithKline plc. Company Details
13.9.2 GlaxoSmithKline plc. Business Overview
13.9.3 GlaxoSmithKline plc. Retropharyngeal Abscess Introduction
13.9.4 GlaxoSmithKline plc. Revenue in Retropharyngeal Abscess Business (2015-2020)
13.9.5 GlaxoSmithKline plc. Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Retropharyngeal Abscess Revenue
1.4 Market by Type
1.4.1 Global Retropharyngeal Abscess Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Antibiotics
1.4.3 Pain Killers
1.4.4 Surgical Drainage
1.4.5 Others
1.5 Market by Application
1.5.1 Global Retropharyngeal Abscess Market Share by Application: 2020 VS 2026
1.5.2 Hospitals and Clinics
1.5.3 Research and Academics
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Retropharyngeal Abscess Market Perspective (2015-2026)
2.2 Global Retropharyngeal Abscess Growth Trends by Regions
2.2.1 Retropharyngeal Abscess Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Retropharyngeal Abscess Historic Market Share by Regions (2015-2020)
2.2.3 Retropharyngeal Abscess Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Retropharyngeal Abscess Market Growth Strategy
2.3.6 Primary Interviews with Key Retropharyngeal Abscess Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Retropharyngeal Abscess Players by Market Size
3.1.1 Global Top Retropharyngeal Abscess Players by Revenue (2015-2020)
3.1.2 Global Retropharyngeal Abscess Revenue Market Share by Players (2015-2020)
3.1.3 Global Retropharyngeal Abscess Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Retropharyngeal Abscess Market Concentration Ratio
3.2.1 Global Retropharyngeal Abscess Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Retropharyngeal Abscess Revenue in 2019
3.3 Retropharyngeal Abscess Key Players Head office and Area Served
3.4 Key Players Retropharyngeal Abscess Product Solution and Service
3.5 Date of Enter into Retropharyngeal Abscess Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Retropharyngeal Abscess Historic Market Size by Type (2015-2020)
4.2 Global Retropharyngeal Abscess Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Retropharyngeal Abscess Market Size by Application (2015-2020)
5.2 Global Retropharyngeal Abscess Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Retropharyngeal Abscess Market Size (2015-2020)
6.2 Retropharyngeal Abscess Key Players in North America (2019-2020)
6.3 North America Retropharyngeal Abscess Market Size by Type (2015-2020)
6.4 North America Retropharyngeal Abscess Market Size by Application (2015-2020)
7 Europe
7.1 Europe Retropharyngeal Abscess Market Size (2015-2020)
7.2 Retropharyngeal Abscess Key Players in Europe (2019-2020)
7.3 Europe Retropharyngeal Abscess Market Size by Type (2015-2020)
7.4 Europe Retropharyngeal Abscess Market Size by Application (2015-2020)
8 China
8.1 China Retropharyngeal Abscess Market Size (2015-2020)
8.2 Retropharyngeal Abscess Key Players in China (2019-2020)
8.3 China Retropharyngeal Abscess Market Size by Type (2015-2020)
8.4 China Retropharyngeal Abscess Market Size by Application (2015-2020)
9 Japan
9.1 Japan Retropharyngeal Abscess Market Size (2015-2020)
9.2 Retropharyngeal Abscess Key Players in Japan (2019-2020)
9.3 Japan Retropharyngeal Abscess Market Size by Type (2015-2020)
9.4 Japan Retropharyngeal Abscess Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Retropharyngeal Abscess Market Size (2015-2020)
10.2 Retropharyngeal Abscess Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Retropharyngeal Abscess Market Size by Type (2015-2020)
10.4 Southeast Asia Retropharyngeal Abscess Market Size by Application (2015-2020)
11 India
11.1 India Retropharyngeal Abscess Market Size (2015-2020)
11.2 Retropharyngeal Abscess Key Players in India (2019-2020)
11.3 India Retropharyngeal Abscess Market Size by Type (2015-2020)
11.4 India Retropharyngeal Abscess Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Retropharyngeal Abscess Market Size (2015-2020)
12.2 Retropharyngeal Abscess Key Players in Central & South America (2019-2020)
12.3 Central & South America Retropharyngeal Abscess Market Size by Type (2015-2020)
12.4 Central & South America Retropharyngeal Abscess Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Merck KGaA
13.1.1 Merck KGaA Company Details
13.1.2 Merck KGaA Business Overview
13.1.3 Merck KGaA Retropharyngeal Abscess Introduction
13.1.4 Merck KGaA Revenue in Retropharyngeal Abscess Business (2015-2020))
13.1.5 Merck KGaA Recent Development
13.2 Johnson & Johnson
13.2.1 Johnson & Johnson Company Details
13.2.2 Johnson & Johnson Business Overview
13.2.3 Johnson & Johnson Retropharyngeal Abscess Introduction
13.2.4 Johnson & Johnson Revenue in Retropharyngeal Abscess Business (2015-2020)
13.2.5 Johnson & Johnson Recent Development
13.3 AstraZeneca plc.
13.3.1 AstraZeneca plc. Company Details
13.3.2 AstraZeneca plc. Business Overview
13.3.3 AstraZeneca plc. Retropharyngeal Abscess Introduction
13.3.4 AstraZeneca plc. Revenue in Retropharyngeal Abscess Business (2015-2020)
13.3.5 AstraZeneca plc. Recent Development
13.4 Sanofi S.A.
13.4.1 Sanofi S.A. Company Details
13.4.2 Sanofi S.A. Business Overview
13.4.3 Sanofi S.A. Retropharyngeal Abscess Introduction
13.4.4 Sanofi S.A. Revenue in Retropharyngeal Abscess Business (2015-2020)
13.4.5 Sanofi S.A. Recent Development
13.5 Pfizer
13.5.1 Pfizer Company Details
13.5.2 Pfizer Business Overview
13.5.3 Pfizer Retropharyngeal Abscess Introduction
13.5.4 Pfizer Revenue in Retropharyngeal Abscess Business (2015-2020)
13.5.5 Pfizer Recent Development
13.6 Mylan N.V.
13.6.1 Mylan N.V. Company Details
13.6.2 Mylan N.V. Business Overview
13.6.3 Mylan N.V. Retropharyngeal Abscess Introduction
13.6.4 Mylan N.V. Revenue in Retropharyngeal Abscess Business (2015-2020)
13.6.5 Mylan N.V. Recent Development
13.7 Novartis AG
13.7.1 Novartis AG Company Details
13.7.2 Novartis AG Business Overview
13.7.3 Novartis AG Retropharyngeal Abscess Introduction
13.7.4 Novartis AG Revenue in Retropharyngeal Abscess Business (2015-2020)
13.7.5 Novartis AG Recent Development
13.8 Teva pharmaceutical company
13.8.1 Teva pharmaceutical company Company Details
13.8.2 Teva pharmaceutical company Business Overview
13.8.3 Teva pharmaceutical company Retropharyngeal Abscess Introduction
13.8.4 Teva pharmaceutical company Revenue in Retropharyngeal Abscess Business (2015-2020)
13.8.5 Teva pharmaceutical company Recent Development
13.9 GlaxoSmithKline plc.
13.9.1 GlaxoSmithKline plc. Company Details
13.9.2 GlaxoSmithKline plc. Business Overview
13.9.3 GlaxoSmithKline plc. Retropharyngeal Abscess Introduction
13.9.4 GlaxoSmithKline plc. Revenue in Retropharyngeal Abscess Business (2015-2020)
13.9.5 GlaxoSmithKline plc. Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
